Working… Menu

Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma (GliAvAx)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03291314
Recruitment Status : Completed
First Posted : September 25, 2017
Last Update Posted : January 23, 2019
Information provided by (Responsible Party):
Bart Neyns, Universitair Ziekenhuis Brussel

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 1, 2019
Actual Study Completion Date : January 1, 2019
Publications of Results:
Other Publications: